ASTRO’s education programs recognized with ACCME accreditation The American Society for Radiation Oncology's education credentials have already been recognized and upgraded by the Accreditation Council for Continuing Medical Education from Accreditation to Accreditation with Commendation, approved in the ACCME's December 2014 meeting. ASTRO's Accreditation position was renewed on March 31, 2014, for four years and has now been extended for two additional years as Accreditation with Commendation until March 31, 2020. The ACCME is the national accrediting table for all medical education companies in the U.S. That administer courses and confer Continuing Medical Education credits to physicians and health care companies. ‘ASTRO can be proud to be known for the outstanding education programs we generate that enhance and fortify the professional skills of the complete radiation oncology treatment team,’ said Bruce G.Fleisher, M.D., Donald B. Kohn, M.D., Jennifer M. Puck, M.D., Luigi D. Notarangelo, M.D., Morton J. Cowan, M.D., and Richard J. O’Reilly, M.D. It is characterized by severe T-cell lymphocytopenia and too little antigen-specific T-cell and B-cell immune responses.2-12 Expanded donor availability and advancements in supportive care and treatment of attacks have improved long-term outcomes after hematopoietic-cell transplantation.10,13-17 However, owing to the rarity and genetic heterogeneity of SCID, questions remain regarding the contributions of individual characteristics, kind of transplant and donor, and conditioning regimen, if used, to survival, immune reconstitution, and the long-term outcome.